Search results
Results From The WOW.Com Content Network
Nandrolone decanoate, sold under the brand names Rolon [7] and Deca-Durabolin, among others, is an androgen and anabolic steroid (AAS) medication which is used primarily in the treatment of anemias and wasting syndromes, as well as osteoporosis in menopausal women.
It is also an anabolic steroid (AAS) which is medically used in the form of esters such as nandrolone decanoate (brand name Deca-Durabolin) and nandrolone phenylpropionate (brand name Durabolin). [ 2 ] [ 12 ] [ 8 ] [ 13 ] Nandrolone esters are used in the treatment of anemias , cachexia ( muscle wasting syndrome), osteoporosis , breast cancer ...
Health risks can be produced by long-term use or excessive doses of AAS. [ 2 ] [ 3 ] These effects include harmful changes in cholesterol levels (increased low-density lipoprotein and decreased high-density lipoprotein ), acne , high blood pressure , liver damage (mainly with most oral AAS), and left ventricular hypertrophy . [ 4 ]
300 mg 3x/week Drostanolone propionate: Oil solution: 100 mg 1–3x/week Metenolone enanthate: Oil solution: 400 mg 3x/week Nandrolone decanoate: Oil solution: 50–100 mg 1x/1–3 weeks Nandrolone phenylpropionate: Oil solution: 50–100 mg/week Note: Dosages are not necessarily equivalent. Sources: See template.
Risks associated with treatment of late-onset hypogonadism [ edit ] There is a potential concern in the medical community that the administration of testosterone therapy for the treatment of late-onset hypogonadism may escalate the risks associated with benign prostatic hyperplasia , prostate cancer and heart diseases.
Testosterone cypionate, sold under the brand name Depo-Testosterone among others, is an androgen and anabolic steroid (AAS) medication which is used mainly in the treatment of low testosterone levels in men, [2] [3] [4] including hormone therapy for transgender men.
Glucuronolactone is an ingredient used in some energy drinks, [2] often in unnaturally high doses. Research into Glucuronolactone is too limited to assert claims about its safety [8] The European Food Safety Authority (EFSA) has concluded that it is unlikely that glucurono-γ-lactone would have any interaction with caffeine, taurine, alcohol or the effects of exercise.
Side effects of vosilasarm in preliminary clinical studies in women with metastatic breast cancer have included vomiting (27%), dehydration (27%), constipation, decreased appetite and weight loss (27%), hypophosphatemia, decreased sex hormone-binding globulin (SHBG) levels (100%), increased prostate-specific antigen (PSA) levels (80%), and abnormal liver function tests, including elevated ...